Biomarkers in peripheral arterial disease patients and near- and longer-term mortality

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages 85-90

  Criqui, Michael H ^a   Ho, Lindsey A ^a,b   Denenberg, Julie O ^a   Ridker, Paul M ^c   Wassel, Christina L ^a   McDermott, Mary M ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; HOMOCYSTEINE; LIPOPROTEIN; SERUM AMYLOID A; THROMBOCYTE ACTIVATING FACTOR;

AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INVASIVE PROCEDURE; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

AGE FACTORS; AGED; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; KAPLAN-MEIERS ESTIMATE; MALE; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 77953687698     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.02.004     Document Type: Article

References (26)

1. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
2. Ridker P.M., Rifai N., Cook N.R., Bradwin G., and Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
3. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., and Fowkes F.G. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation 115 (2007) 2119-2127
4. Ridker P.M. High sensitive C-reactive protein as a predictor of all-cause mortality: Implications for research and patient care. Clin Chem 54 (2008) 234-237
5. Zethelius B., Berglund L., Sundström J., Ingelsson E., Basu S., Larsson A., et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358 (2008) 2107-2116
6. Tracy R., Lemaitre R., Psaty B., Ives G., Evans R.W., Cushman M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol 17 (1997) 1121-1127
7. Cushman M., Lemaitre R.N., Kuller L.H., Psaty B.M., Macy E.M., Sharrett A.R., et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 19 (1999) 493-498
8. Pirro M., Bergeron J., Dagenais G.R., Bernard P., Cantin B., Despres J., et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med 161 (2001) 2474-2480
9. Sakkinen P., Abbott R.D., Curb J.D., Rodriguez B.L., Yano K., and Tracy R.P. C-reactive protein and myocardial infarction. J Clinical Epidemiol 55 (2002) 445-451
10. Jenny N.S., Yanez N.D., Psaty B.M., Kuller L.H., Hirsch C.H., and Tracy R.P. Inflammation biomarkers and near-term death in older men. Am J Epidemiol 165 (2007) 684-695
11. Vidula H., Tian L., Liu K., Criqui M.H., Ferrucci L., Pearce W.H., et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Int Med 148 (2008) 85-93
12. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
13. Bird C.E., Criqui M.H., Fronek A., Denenberg J.O., Klauber M.R., and Langer R.D. Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 4 (1999) 15-21
14. Shadman R., Allison M.A., and Criqui M.H. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients. J Am Coll Card 49 (2007) 2172-2181
15. Allison M.A., Denenberg J.O., Nelson J.J., Natarajan L., and Criqui M.H. The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients. J Vasc Surg 46 (2007) 500-506
16. Shadman R., Criqui M.H., Bundens W.P., Fronek A., Denenberg J.O., Gamst A.C., et al. Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular disease. J Am Coll Cardiol 44 (2004) 618-623
17. Grambsch P., and Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
18. Wang T.J., Gona P., Larson M.G., Tofler G.H., Levy D., Newton-Cheh C., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355 (2006) 2631-2639
19. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., and Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008) 157-172
20. SAS 9.1 for Windows, Copyright 2002-2003 by SAS Institute Inc., Cary, NC, USA.
21. Ware J.H. The limitations of risk factors as prognostic tools. N Engl J Med 355 (2006) 2615-2617
22. Cook N.R., Buring J.E., and Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 145 (2006) 21-29
23. Cook N.R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115 (2007) 928-935
24. Ridker P.M., Buring J.E., Rifai N., and Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297 (2007) 611-619
25. Pearte C.A., Furberg C.D., O'Meara E.S., Psaty B.M., Kuller L., Powe N.R., et al. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Circulation 113 (2006) 2177-2185
26. Elliot P., Chambers J.C., Zhang W., Clarke R., Hopewell J.C., Peden J.F., et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302 (2009) 37-48